Acacia subsidiary obtains patent for stent graft technology

Published on September 11, 2012 at 8:11 AM · No Comments

Acacia Research Corp (Nasdaq:ACTG) announced today that a subsidiary has acquired a patent for stent graft technology.    

"Acacia continues to increase the number of patent portfolios we control in the medical device and diagnostics sectors," commented Paul Ryan, CEO. "Acacia is expanding its presence as a leader in patent licensing for both the technology and medical technology sectors."

Source:

ACACIA RESEARCH CORPORATION        

Posted in: Device / Technology News | Medical Patent News

Tags: ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’